← Nathan Hager

What podcasts say about Nathan Hager

Every statement, with the speaker, the exact quote and the moment it was said.

What Nathan Hager has said on podcasts

33 statements · 14 positive · 15 negative · 4 neutral

  1. on Supreme Court public trustNegativeOct 5, 2026· Bloomberg Daybreak: US Edition

    Public approval and trust in the Supreme Court are historically low.

    “34% of Americans approve of the high court and only 46% trust its decisions”

    Listen at 5:26

    Open the episode · Yemen Attacks Houthis; Anthropic Researcher to Testify
  2. on EuroNegativeOct 5, 2026· Bloomberg Daybreak: US Edition

    The euro is at a 17-month low against the dollar.

    “the euro is trading at a 17-month low against the dollar”

    Listen at 6:50

    Open the episode · Yemen Attacks Houthis; Anthropic Researcher to Testify
  3. on Flávio BolsonaroPositiveOct 5, 2026· Bloomberg Daybreak: US Edition

    Flávio Bolsonaro is favored to win Brazil's presidential runoff.

    “right-wing candidate Flávio Bolsonaro is the favorite to become the next president”

    Listen at 8:11

    Open the episode · Yemen Attacks Houthis; Anthropic Researcher to Testify
  4. on Meta $2 trillion valuationPositiveSep 25, 2026· Bloomberg Daybreak: US Edition

    Meta is about 1% below a $2 trillion valuation.

    “Meta is roughly 1% gain away from joining an elite group of companies worth at least $2 trillion.”

    Listen at 9:15

    Open the episode · Trump-Xi High-Stakes Summit; Possible Deal to Open Hormuz
  5. on OpenAI and Anthropic IPO valuationsPositiveSep 24, 2026· Bloomberg Daybreak: US Edition

    OpenAI and Anthropic could each be valued near $1 trillion in IPOs.

    “could value each company at nearly $1 trillion.”

    Listen at 6:54

    Open the episode · Trump-Xi Reach Truce Extension; Iran Defiant at UN
  6. on U.S.-Denmark-Greenland security dealNeutralSep 22, 2026· Bloomberg Daybreak: US Edition

    The Greenland security deal will expand U.S. military involvement without transferring sovereignty

    “The deal will expand Washington's military role without granting the U.S. ownership or outright control of Greenland”

    Listen at 4:07

    Open the episode · US-China Negotiate AI and Trade; Trump's High Stakes UN Speech
  7. on Critical Metals European Lithium acquisitionPositiveSep 21, 2026· Stock Movers

    Critical Metals’ European Lithium acquisition gave it full ownership of a Greenland rare-earth project.

    “it's because it acquired European lithium and that gave it full ownership of a rare earth project in Greenland.”

    Listen at 2:21

    Open the episode · Novo Declines; Critical Metals Soars; WBD Higher
  8. on Paramount Skydance film-production penaltyNegativeSep 21, 2026· Stock Movers

    Paramount Skydance could face a $30 million penalty per missed film.

    “And it has a potential penalty of $30 million for each film.”

    Listen at 3:00

    Open the episode · Novo Declines; Critical Metals Soars; WBD Higher
  9. on Paramount $110 billion acquisitionNegativeSep 21, 2026· Stock Movers

    Twelve Democratic state attorneys general and the Writers Guild sued to block Paramount’s acquisition.

    “Attorney generals from 12 states, all Democrats, as well as the Writers Guild Trade Union, have sued to block Paramount's $110 billion acquisition.”

    Listen at 3:16

    Open the episode · Novo Declines; Critical Metals Soars; WBD Higher
  10. on Accenture-Anthropic AI safety partnershipPositiveSep 21, 2026· Stock Movers

    Accenture and Anthropic are partnering to test AI-model safety.

    “Accenture is partnering with Anthropic to test the safety of AI models.”

    Listen at 3:39

    Open the episode · Novo Declines; Critical Metals Soars; WBD Higher
  11. on AI model evaluationsPositiveSep 21, 2026· Stock Movers

    Accenture will evaluate models, test safeguards, and assess alignment with human preferences.

    “So Accenture will be used to evaluate the newest models, test safeguards, and ensure the technology is aligned with what humans actually want.”

    Listen at 3:43

    Open the episode · Novo Declines; Critical Metals Soars; WBD Higher
  12. on Accenture AI-model accessPositiveSep 21, 2026· Stock Movers

    Accenture evaluators have access comparable to Anthropic employees’ model access.

    “Accenture's evaluators have been given similar access as Anthropic's employees”

    Listen at 3:52

    Open the episode · Novo Declines; Critical Metals Soars; WBD Higher
  13. on Oil supply disruptionNegativeSep 18, 2026· Bloomberg Daybreak: US Edition

    Markets price an additional four million barrels per day of oil disruption.

    “Markets are pricing an additional 4 million barrels a day of oil disruption on top of the 10 million now.”

    Listen at 5:01

    Open the episode · Tariffs on Hold Until US-China Summit; AI Existential Risks
  14. on OpenAI IPONegativeSep 16, 2026· Bloomberg Daybreak: US Edition

    Additional funding could allow OpenAI to delay its IPO until 2027

    “the additional funding provides flexibility to push back the IPO until 2027.”

    Listen at 4:48

    Open the episode · Congress, Zuckerberg Address AI Dangers; EU Proposes Canada Membership
  15. on Clarity ActNegativeSep 16, 2026· Bloomberg Daybreak: US Edition

    The Senate failed to advance the Clarity Act

    “The Senate has failed to advance the Clarity Act”

    Listen at 9:32

    Open the episode · Congress, Zuckerberg Address AI Dangers; EU Proposes Canada Membership
  16. on SEC and CFTC crypto rulesNegativeSep 16, 2026· Bloomberg Daybreak: US Edition

    SEC and CFTC crypto rules may be easier for future administrations to change

    “This means regulators like the Securities and Exchange Commission and... Commodity Futures Trading Commission will continue to make crypto rules that could be easier for a future administration to change.”

    Listen at 9:40

    Open the episode · Congress, Zuckerberg Address AI Dangers; EU Proposes Canada Membership
  17. on Supreme Court mail-ballot rulingPositiveSep 15, 2026· Bloomberg Daybreak: US Edition

    The Supreme Court ruling allows states to continue existing mail-ballot processes.

    “The decision allows states to continue sending ballots under existing processes used by nearly one third of voters.”

    Listen at 2:13

    Open the episode · Trump Mail-In Request Rejected; Obama Weighs In on AI
  18. on Bank of Japan October rate hikeNeutralSep 11, 2026· Bloomberg Daybreak: US Edition

    An October BOJ rate hike would surprise markets

    “If they did one in October... That would definitely be a surprise.”

    Listen at 35:16

    Open the episode · Daybreak Weekend: Fed Decision, Sweden Election, BOJ Meeting
  19. on Japan yen interventionNeutralSep 11, 2026· Bloomberg Daybreak: US Edition

    Japan appears to have sold Treasuries to fund yen intervention

    “it does look like Japan sold off a portion of the Treasury's holdings to fund the latest intervention.”

    Listen at 35:54

    Open the episode · Daybreak Weekend: Fed Decision, Sweden Election, BOJ Meeting
  20. on Japan-U.S. yen intervention coordinationNeutralSep 11, 2026· Bloomberg Daybreak: US Edition

    Japan likely coordinated Treasury sales with the United States

    “we also believe that they must have talked to the U.S. about that in advance.”

    Listen at 36:00

    Open the episode · Daybreak Weekend: Fed Decision, Sweden Election, BOJ Meeting
  21. on Palo Alto Networks, Inc.PositiveAug 30, 2026· Stock Movers

    Palo Alto Networks’ market value has nearly doubled since the year began.

    “since the start of the year, we've already seen just Palo Alto alone nearly double its stock market value”

    Listen at 2:07

    Open the episode · Week Ahead: Palo Alto Networks, Broadcom, Lululemon (Podcast)
  22. on The Home Depot, Inc.PositiveAug 18, 2026· Stock Movers

    Home Depot is performing despite weakness in the housing market.

    “Home Depot still finding a way”

    Listen at 1:06

    Open the episode · Home Depot Gains on Earnings; Baidu Slips on Outflows; Alibaba Jumps
  23. on AstraZeneca–Bristol Myers Squibb merger approvalNegativeAug 3, 2026· Stock Movers

    Nathan Hager doubts regulators will approve the AstraZeneca–Bristol Myers Squibb deal.

    “you can't imagine these, or at least I can't imagine these two companies getting regulatory approval.”

    Listen at 3:17

    Open the episode · Bristol-Myers Squibb Potential Merger; SpaceX to Report; Tyson Drops
  24. on U.S. administration mega-deal policyPositiveAug 3, 2026· Stock Movers

    The current administration is viewed as favorable to pursuing mega-deals now.

    “if you want a mega deal, now is the time.”

    Listen at 3:29

    Open the episode · Bristol-Myers Squibb Potential Merger; SpaceX to Report; Tyson Drops
  25. on SpaceXNegativeJun 23, 2026· Stock Movers

    SpaceX has not yet become profitable.

    “SpaceX has yet to turn a profit.”

    Listen at 1:59

    Open the episode · SpaceX Slides and AMC Tumbles
  26. on SpaceXNegativeJun 23, 2026· Stock Movers

    SpaceX will continue burning cash through 2029.

    “it's going to keep burning cash through 2029, according to S and P Global.”

    Listen at 2:03

    Open the episode · SpaceX Slides and AMC Tumbles
  27. AMC shares fell more than 24%.

    “AMC shares are sinking by more than 24%.”

    Listen at 3:45

    Open the episode · SpaceX Slides and AMC Tumbles
  28. AMC's share sale could cause nearly 15% dilution for common stockholders.

    “Bloomberg Intelligence is suggesting close to 15% dilution for common stockholders in American Multi Cinema.”

    Listen at 4:01

    Open the episode · SpaceX Slides and AMC Tumbles
  29. on AbbVie acquisition of Apogee TherapeuticsPositiveJun 22, 2026· Stock Movers

    AbbVie is acquiring Apogee Therapeutics for $10.9 billion.

    “Abbvie is buying apogee for $10.9 billion”

    Listen at 0:53

    Open the episode · Apogee-AbbVie; Regenxbio and FDA News; SpaceX Decline
  30. on Apogee TherapeuticsPositiveJun 22, 2026· Stock Movers

    Apogee has a promising experimental psoriasis compound.

    “that company's got a promising experimental compound for psoriasis”

    Listen at 1:18

    Open the episode · Apogee-AbbVie; Regenxbio and FDA News; SpaceX Decline

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Nathan Hager: what podcasts say · PodLume